Methylation of TFPI2 in Stool DNA: A Potential Novel Biomarker for the Detection of Colorectal Cancer

被引：199

作者：

Gloeckner, Sabine C. ^{[1
,7
]}

Dhir, Mashaal ^{[1
]}

Yi, Joo Mi ^{[2
]}

McGarvey, Kelly E. ^{[2
]}

Van Neste, Leander ^{[4
]}

Louwagie, Joost ^{[5
]}

Chan, Timothy A. ^{[6
]}

Kleeberger, Wolfram ^{[2
,7
]}

de Bruine, Adriaan P. ^{[8
]}

Smits, Kim M. ^{[8
]}

Bakker, Carolina A. J. Khalid-de ^{[9
]}

Jonkers, Daisy M. A. E. ^{[9
]}

Stockbruegger, Reinhold W. ^{[9
]}

Meijer, Gerrit A. ^{[10
]}

Oort, Frank A. ^{[11
]}

Iacobuzio-Donahue, Christine ^{[3
]}

Bierau, Katja ^{[5
]}

Herman, James G. ^{[2
]}

Baylin, Stephen B. ^{[2
]}

Van Engeland, Marion ^{[8
]}

Schuebe, Kornel E. ^{[2
]}

Ahuja, Nita ^{[1
,2
]}

机构：

[1] Johns Hopkins Univ, Dept Surg, Baltimore, MD USA

[2] Johns Hopkins Univ, Dept Oncol, Baltimore, MD USA

[3] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA

[4] Univ Ghent, Fac Biosci Engn, Dept Mol Biotechnol, B-9000 Ghent, Belgium

[5] Oncomethylome Sci SA, Liege, Belgium

[6] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA

[7] Univ Regensburg, Dept Pathol, Regensburg, Germany

[8] Maastricht Univ, Med Ctr, Dept Pathol, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands

[9] Maastricht Univ, Med Ctr, Div Gastroenterol & Hepatol, Dept Internal Med, Maastricht, Netherlands

[10] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands

[11] Vrije Univ Amsterdam, Med Ctr, Dept Gastroenterol, Amsterdam, Netherlands

来源：

CANCER RESEARCH | 2009年 / 69卷 / 11期

关键词：

FACTOR PATHWAY INHIBITOR-2; FECAL OCCULT BLOOD; CHROMATIN PATTERN; CELL FATE; GENE; HYPERMETHYLATION; MUTATIONS; MARKER; SFRP2; MECHANISM;

D O I：

10.1158/0008-5472.CAN-08-0142

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

We have used a gene expression array-based strategy to identify the methylation of tissue factor pathway inhibitor 2 (TFPI2), a potential tumor suppressor gene, as a frequent event in human colorectal cancers (CRC). TFPI2 belongs to the recently described group of embryonic cell Polycomb group (PcG)-marked genes that may be predisposed to aberrant DNA methylation in early stages of colorectal carcinogenesis. Aberrant methylation of TFPI2 was detected in almost all CRC adenomas (97%, n = 56) and stages I to IV CRCs (99%, n = 115). We further explored the potential of TFPI2 as a biomarker for the early detection of CRC using stool DNA-based assays in patients with nonmetastatic CRC and average-risk noncancer controls who were candidates for screening. TFPI2 methylation was detected in stool DNA from stage I to III CRC patients with a sensitivity of 76% to 89% and a specificity of 79% to 93%. Detection of TFPI2 methylation in stool DNA may act as a useful adjunct to the noninvasive strategies for screening of CRCs in the future. [Cancer Res 2009;69(11):4691-9]

引用

页码：4691 / 4699

页数：9

共 38 条

[1] Stool DNA and occult blood testing for screen detection of colorectal neoplasia [J].

Ahlquist, David A. ;

Sargent, Daniel J. ;

Loprinzi, Charles L. ;

Levin, Theodore R. ;

Rex, Douglas K. ;

Ahnen, Dennis J. ;

Knigge, Kandice ;

Lance, Peter ;

Burgart, Lawrence J. ;

Hamilton, Stanley R. ;

Allison, James E. ;

Lawson, Michael J. ;

Devens, Mary E. ;

Harrington, Jonathan J. ;

Hillman, Shauna L. .

ANNALS OF INTERNAL MEDICINE, 2008, 149 (07) :441-W81

[2] High-resolution profiling of histone methylations in the human genome [J].

Barski, Artern ;

Cuddapah, Suresh ;

Cui, Kairong ;

Roh, Tae-Young ;

Schones, Dustin E. ;

Wang, Zhibin ;

Wei, Gang ;

Chepelev, Iouri ;

Zhao, Keji .

CELL, 2007, 129 (04) :823-837

[3] A bivalent chromatin structure marks key developmental genes in embryonic stem cells [J].

Bernstein, BE ;

Mikkelsen, TS ;

Xie, XH ;

Kamal, M ;

Huebert, DJ ;

Cuff, J ;

Fry, B ;

Meissner, A ;

Wernig, M ;

Plath, K ;

Jaenisch, R ;

Wagschal, A ;

Feil, R ;

Schreiber, SL ;

Lander, ES .

CELL, 2006, 125 (02) :315-326

[4] Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions [J].

Bracken, AP ;

Dietrich, N ;

Pasini, D ;

Hansen, KH ;

Helin, K .

GENES & DEVELOPMENT, 2006, 20 (09) :1123-1136

[5] Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene [J].

Chen, WD ;

Han, ZJ ;

Skoletsky, J ;

Olson, J ;

Sah, J ;

Myeroff, L ;

Platzer, P ;

Lu, SL ;

Dawson, D ;

Willis, J ;

Pretlow, TR ;

Lutterbaugh, J ;

Kasturi, L ;

Willson, JKV ;

Rao, JS ;

Shuber, A ;

Markowitz, SD .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (15) :1124-1132

[6] Analysis of mutations in DNA isolated from plasma and stool of colorectal cancer patients [J].

Diehl, Frank ;

Schmidt, Kerstin ;

Durkee, Kristine H. ;

Moore, Kent J. ;

Goodman, Steve N. ;

Shuber, Anthony P. ;

Kinzler, Kenneth W. ;

Vogelstein, Bert .

GASTROENTEROLOGY, 2008, 135 (02) :489-498

[7]

Heresbach D, 2006, EUR J GASTROEN HEPAT, V18, P427, DOI 10.1097/00042737-200604000-00018

[8] Mechanisms of disease: Gene silencing in cancer in association with promoter hypermethylation [J].

Herman, JG ;

Baylin, SB .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (21) :2042-2054

[9] Hypermethylation of SFRP2 as a potential marker for stool-based detection of colorectal cancer and precancerous lesions [J].

Huang, Zhaohui ;

Li, Lihua ;

Wang, Jinfu .

DIGESTIVE DISEASES AND SCIENCES, 2007, 52 (09) :2287-2291

[10] Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population [J].

Imperiale, TF ;

Ransohoff, DF ;

Itzkowitz, SH ;

Turnbull, BA ;

Ross, ME .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (26) :2704-2714

← 1 2 3 4 →